Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Synlogic, Inc. (NASDAQ:SYBX – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 695,800 shares, an increase of 141.0% from the April 30th total of 288,700 shares. Currently, 1.6% of the company’s stock are short sold. Based on […]
Synlogic, Inc. (NASDAQ:SYBX – Get Rating) saw a significant increase in short interest in May. As of May 15th, there was short interest totalling 695,800 shares, an increase of 141.0% from the April 30th total of 288,700 shares. Currently, 1.6% of the company’s stock are short sold. Based on an average daily volume of 296,800 […]
CAMBRIDGE, Mass., May 23, 2023 -- Synlogic, Inc. , the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B. Ch.B., President and Chief... | May 23, 2023
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update - Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023 - ... | May 11, 2023
- Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – - Recent milestones include receipt of Rare Pediatric and...